advanced they might be but it's still a concern about buyers. It's not a good time for biotechs generally they've been depressed for a long time so, it's only results that count. PTX can't rest on their previous results without providing timing guidance about future trial outcomes. Today's sp failure might be due to one holder offloading which normally wouldn't matter, but support for PTX is so weak even small volume sells will dramatically affect price. Current lack of depth would prevent me from any buying.
PTX Price at posting:
8.9¢ Sentiment: Hold Disclosure: Held
